Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.5 USD | +0.67% | -7.41% | -57.17% |
May. 14 | Transcript : TRACON Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | Earnings Flash (TCON) TRACON PHARMACEUTICALS Posts Q1 Revenue $100,000 | MT |
Business Summary
Number of employees: 17
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Therapeutics
100.0
%
| 0 | nan % | 12 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 12 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Charles Theuer
CEO | Chief Executive Officer | 60 | 06-06-30 |
Scott Brown
DFI | Director of Finance/CFO | 43 | 15-07-31 |
James L. Freddo
CTO | Chief Tech/Sci/R&D Officer | 69 | 20-04-30 |
Brenda Marczi
LAW | General Counsel | - | 21-07-19 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Martin Mattingly
BRD | Director/Board Member | 66 | 14-12-25 |
Director/Board Member | 54 | 20-03-18 | |
Stephen Worland
BRD | Director/Board Member | 66 | 15-02-24 |
Rainer Twiford
BRD | Director/Board Member | 71 | 08-08-31 |
William LaRue
BRD | Director/Board Member | 73 | 14-06-30 |
Charles Theuer
CEO | Chief Executive Officer | 60 | 06-06-30 |
Carol Lam
BRD | Director/Board Member | 64 | 21-10-11 |
Director/Board Member | 60 | 21-03-01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 2,679,035 | 2,620,001 ( 97.80 %) | 0 | 97.80 % |
Company contact information
TRACON Pharmaceuticals, Inc.
4350 La Jolla Village Drive Suite 800
92122-1243, San Diego
+
http://www.traconpharma.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-57.17% | 3.41M | |
-1.62% | 89.22B | |
+2.24% | 40.49B | |
-12.97% | 32.79B | |
+63.37% | 26.23B | |
-20.71% | 14.52B | |
-7.31% | 13.09B | |
-12.64% | 11.5B | |
-42.60% | 11.6B | |
+5.09% | 8.82B |
- Stock Market
- Equities
- TCON Stock
- Company TRACON Pharmaceuticals, Inc.